Company: ANP Pharma, WesCom
Business Type: Marine Safety Solutions / Search and Rescue
UK & International Business Sales and M&A News
Survival solutions manufacturer Wescom Group has acquired leading medical supplies company ANP Pharma, to expand its presence in the maritime market.
ANP Pharma, based in Essex, UK, is a leading supplier for regulated pharmaceuticals in the marine sector, and one of the fastest growing single-source suppliers of complete medical solutions worldwide.The company is registered with the Royal Pharmaceutical Society of Great Britain (RPSGB) and is licensed by the Medicines and Healthcare Products Regulatory Agency (MHRA).
It offers a range of services, including supply of regulated medicines for medical stores, vessel medical supply audits and remote medical support services for a range of marine sectors, including commercial, offshore, leisure craft and cruise ships.
ANP’s CEO Chris Curran commented:
“Thanks to our shared maritime focus and combined distribution knowledge, this is an incredible opportunity to accelerate the company’s growth into new markets.”
Chris Curran - CEO of ANP Pharma
Wescom, with its head office in Derbyshire, has specialist manufacturing facilities for survival solutions across four sites in Germany, UK, Spain and Australia, from where it designs, manufactures and distributes pyrotechnic rescue signalling devices.
Ross Wilkinson, Chief Executive Officer of Wescom Group, said:
“I’m delighted to announce that ANP Pharma joins Wescom Group. ANP’s expertise in sourcing and global distributing of marine pharmaceuticals enhances our current critical survival capabilities and helps our customers overcome challenging regulatory barriers.
“We are excited to work with the management team in growing the business both organically and geographically.”
Ross Wilkinson – CEO of Wescom Group
ANP Pharma expands Wescom Group’s portfolio and complements its business model of global distribution of highly regulated marine safety equipment to mandated end-user markets.
Wescom Group’s move into global marine pharmaceutical distribution follows last year’s purchase of MRT’s distress electronics and is equally complimentary to the company’s long-term ambitions.
Comments
No comment yet.